Edesa Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2018	2017	2016	2015	2014	2013	2012 - 2011
Net Income	-8.37	-17.55	-13.34	-6.36	-1.87	-5.03	-5.03	-2.84	-8.44	-14.5	Upgrade
Depreciation & Amortization	0.18	0.12	0.12	0.06	0	0.18	0.15	0.16	0.16	0.12	Upgrade
Share-Based Compensation	1.25	2.26	3.2	0.6	0.08	0.12	0.26	0.27	0.96	0.79	Upgrade
Other Operating Activities	0.31	2.89	-3.64	0.72	0.49	0.04	0.11	-2	3.06	10.79	Upgrade
Operating Cash Flow	-6.64	-12.28	-13.66	-4.99	-1.29	-4.7	-4.51	-4.41	-4.27	-2.8	Upgrade
Capital Expenditures	0	-0.01	-0.01	0.05	-0.01	-0.3	-0.4	-0.27	-0.28	-0.01	Upgrade
Acquisitions	0	0	0	0	0	0	-0.07	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	1.99	1.03	0.4	-5.47	0	Upgrade
Other Investing Activities	-	-	-	-0.03	-	-	-	-	-	-	Upgrade
Investing Cash Flow	0	-0.01	-0.01	0.02	-0.01	1.69	0.56	0.12	-5.75	-0.01	Upgrade
Share Issuance / Repurchase	4.83	11.63	14.17	7.12	0	0	7.65	0.11	10.92	9.73	Upgrade
Debt Issued / Paid	0	0	0	0.03	0	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-0.06	-	-	-0.33	-	-0.13	0	Upgrade
Financing Cash Flow	4.83	11.63	14.17	7.09	0	0	7.31	0.11	10.79	9.73	Upgrade
Exchange Rate Effect	0.08	-0.09	0.12	0.06	-0.34	0.16	0.1	-0.63	-0.21	-0.06	Upgrade
Net Cash Flow	-1.73	-0.75	0.63	2.18	-1.63	-2.85	3.46	-4.81	0.56	6.86	Upgrade
Free Cash Flow	-6.64	-12.28	-13.67	-4.94	-1.3	-5	-4.91	-4.69	-4.54	-2.81	Upgrade
Free Cash Flow Margin	-	-	-	-1501.75%	-	-2191.27%	-385.94%	-617.77%	-1220.97%	-514.30%	Upgrade
Free Cash Flow Per Share	-2.32	-5.86	-7.92	-4.02	-2.80	-143.66	-163.48	-173.18	-176.17	-159.80	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).